| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |